These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33796198)

  • 1. Immunisation program reviews in East and Southern Africa: 2012-2018; key lessons.
    Shibeshi ME; Masresha BG; Daniel F
    Pan Afr Med J; 2020; 37():385. PubMed ID: 33796198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation program reviews in East and Southern Africa (2012-2018): key lessons.
    Shibeshi ME; Masresha BG; Daniel F
    Pan Afr Med J; 2021; 38():194. PubMed ID: 33995800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries.
    Bello IM; Lebo E; Shibeshi ME; Akpan GU; Chakauya J; Masresha BG; Daniel F
    Pan Afr Med J; 2021; 38():164. PubMed ID: 33995771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunisation program training needs in 9 countries in the African Region.
    Masresha BG; Dochez C; Bwaka A; Eshetu M; Paluku G; Mihigo R
    Pan Afr Med J; 2021; 39():41. PubMed ID: 34422164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Training needs for mid-level managers and immunisation coverage in Western Kenya.
    Ayaya SO; Liechty E; Conway JH; Kamau T; Esamai FO
    East Afr Med J; 2007 Jul; 84(7):342-52. PubMed ID: 17886429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews.
    Wiysonge CS; Ngcobo NJ; Jeena PM; Madhi SA; Schoub BD; Hawkridge A; Shey MS; Hussey GD
    BMC Public Health; 2012 Jul; 12():578. PubMed ID: 22849711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution and use of feedback bulletins among national immunization program management teams in East and Southern Africa.
    Masresha BG; Weldegebriel G; Lebo E; Chakauya J; Fussum D
    Pan Afr Med J; 2020; 35(Suppl 1):4. PubMed ID: 32373255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equity and immunization supply chain in Madagascar.
    van den Ent MMVX; Yameogo A; Ribaira E; Hanson CM; Ratoto R; Rasolomanana S; Foncha C; Gasse F
    Vaccine; 2017 Apr; 35(17):2148-2154. PubMed ID: 28364923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
    Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaps in vaccine management practices during vaccination outreach sessions in rural settings in southwestern Uganda.
    Flavia A; Fred B; Eleanor T
    BMC Infect Dis; 2023 Nov; 23(1):758. PubMed ID: 37924008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System within systems: challenges and opportunities for the Expanded Programme on Immunisation in Pakistan.
    Haq Z; Shaikh BT; Tran N; Hafeez A; Ghaffar A
    Health Res Policy Syst; 2019 May; 17(1):51. PubMed ID: 31101060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing an effective and sustainable national immunisation programme in China: issues and challenges.
    Chen S; Yao L; Wang W; Tang S
    Lancet Public Health; 2022 Dec; 7(12):e1064-e1072. PubMed ID: 36252582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine stockouts around the world: Are essential vaccines always available when needed?
    Lydon P; Schreiber B; Gasca A; Dumolard L; Urfer D; Senouci K
    Vaccine; 2017 Apr; 35(17):2121-2126. PubMed ID: 28364919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Conflict on Immunisation Coverage in 16 Countries.
    Grundy J; Biggs BA
    Int J Health Policy Manag; 2019 Apr; 8(4):211-221. PubMed ID: 31050966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya.
    Tesfaye B; K Makam J; Sergon K; Onuekwusi I; Muitherero C; Sowe A
    BMC Public Health; 2020 Jul; 20(1):1110. PubMed ID: 32664859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.